1022091-93-5 Usage
Uses
Used in Organic Synthesis:
3-Bromo-6-quinolineacetic acid is utilized as a key intermediate in organic synthesis for the creation of a range of chemical compounds. Its unique reactivity and functional groups make it an ideal candidate for the development of new organic molecules with potential applications in various industries.
Used in Drug Development:
In the pharmaceutical industry, 3-Bromo-6-quinolineacetic acid is employed as a precursor in the synthesis of drugs with potential therapeutic properties. Its incorporation into drug molecules can enhance their bioactivity, leading to the discovery of new medications for the treatment of various diseases.
Used in Medicinal Chemistry Research:
3-Bromo-6-quinolineacetic acid is used as a research tool in medicinal chemistry to explore its potential as a lead compound for drug discovery. Its unique structure allows researchers to investigate its interactions with biological targets, providing insights into the development of novel therapeutic agents.
Used in Drug Discovery Efforts:
As a part of drug discovery initiatives, 3-Bromo-6-quinolineacetic acid is leveraged to identify new bioactive compounds with potential pharmaceutical applications. Its versatility in chemical reactions and ability to form diverse molecular structures make it a promising starting point for the development of innovative drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 1022091-93-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,2,0,9 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1022091-93:
(9*1)+(8*0)+(7*2)+(6*2)+(5*0)+(4*9)+(3*1)+(2*9)+(1*3)=95
95 % 10 = 5
So 1022091-93-5 is a valid CAS Registry Number.
1022091-93-5Relevant academic research and scientific papers
HETEROCYCLIC KINASE MODULATORS
-
Page/Page column 115, (2009/01/20)
The present disclosure provides heterocyclic protein kinase modulators and methods of using these compounds to treat diseases mediated by kinase activity.
